{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:20:24Z","timestamp":1775341224094,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,14]]},"DOI":"10.7759\/cureus.66888","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T21:25:20Z","timestamp":1723670720000},"source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of \u03b2-Blockers in Decreasing Mortality in Sepsis and Septic Shock Patients: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Alekya","family":"Perala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annetta V","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranim K","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Entesar","family":"Elsaady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Rizwan","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1143090","article-title":"Role of aspirin, beta-blocker, statins, and heparin therapy in septic patients under mechanical ventilation: a narrative review","volume":"10","author":"Al-Husinat L","year":"2023","unstructured":"Al-Husinat L, Abu Hmaid A, Abbas H, et al.. Role of aspirin, beta-blocker, statins, and heparin therapy in septic patients under mechanical ventilation: a narrative review. Front Med (Lausanne). 2023, 10:10.3389\/fmed.2023.1143090","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1272871","article-title":"Association between the \u03b2-blocker use and patients with sepsis: a cohort study","volume":"10","author":"Yang Q","year":"2023","unstructured":"Yang Q, Kong T, Bao Z, et al.. Association between the \u03b2-blocker use and patients with sepsis: a cohort study. Front Med (Lausanne). 2023, 10:10.3389\/fmed.2023.1272871","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-023-01983-8","article-title":"Evaluating the effects of esmolol on cardiac function in patients with septic cardiomyopathy by speck-tracking echocardiography - a randomized controlled trial","volume":"23","author":"Wang J","year":"2023","unstructured":"Wang J, Gao X, He Z, Wang J, Xu G, Li T. Evaluating the effects of esmolol on cardiac function in patients with septic cardiomyopathy by speck-tracking echocardiography - a randomized controlled trial. BMC Anesthesiol. 2023, 23:10.1186\/s12871-023-01983-8","journal-title":"BMC Anesthesiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1121444","article-title":"Effect of \u03b2-blockers on mortality in patients with sepsis: a propensity-score matched analysis","volume":"13","author":"Ge CL","year":"2023","unstructured":"Ge CL, Zhang LN, Ai YH, Chen W, Ye ZW, Zou Y, Peng QY. Effect of \u03b2-blockers on mortality in patients with sepsis: a propensity-score matched analysis. Front Cell Infect Microbiol. 2023, 13:10.3389\/fcimb.2023.1121444","journal-title":"Front Cell Infect Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154916","article-title":"Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: a systematic review and meta-analysis of randomized controlled studies","volume":"126","author":"Li J","year":"2020","unstructured":"Li J, Sun W, Guo Y, Ren Y, Li Y, Yang Z. Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: a systematic review and meta-analysis of randomized controlled studies. Cytokine. 2020, 126:10.1016\/j.cyto.2019.154916","journal-title":"Cytokine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5935\/0103-507X.20170001","article-title":"\u03b2-blockers in septic shock: are we there yet?","volume":"29","author":"Cruz MC","year":"2017","unstructured":"Cruz MC, Reis L. \u03b2-blockers in septic shock: are we there yet?. Rev Bras Ter Intensiva. 2017, 29:1-3. 10.5935\/0103-507X.20170001","journal-title":"Rev Bras Ter Intensiva"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s42077-020-00107-5","article-title":"Evaluation of the safety and efficacy of beta blockers in septic patients: a randomized control trial","volume":"12","author":"Gadallah RR","year":"2020","unstructured":"Gadallah RR, Aboseif EMK, Ibrahim DA, Zaki HV, Abdelmaksoud MNM. Evaluation of the safety and efficacy of beta blockers in septic patients: a randomized control trial. Ain-Shams J Anesthesiol. 2020, 12:10.1186\/s42077-020-00107-5","journal-title":"Ain-Shams J Anesthesiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-22-00125","article-title":"Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process","volume":"21","author":"Barker TH","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, et al.. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023, 21:478-93. 10.11124\/JBIES-22-00125","journal-title":"JBI Evid Synth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA - a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA - a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/2197-425X-3-S1-A88","article-title":"90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment","volume":"3","author":"Fuchs C","year":"2015","unstructured":"Fuchs C, Scheer C, Wauschkuhn S, et al.. 90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment. Intensive Care Med Exp. 2015, 3:10.1186\/2197-425X-3-S1-A88","journal-title":"Intensive Care Med Exp"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.11.013","article-title":"The influence of esmolol on septic shock and sepsis: a meta-analysis of randomized controlled studies","volume":"36","author":"Liu P","year":"2018","unstructured":"Liu P, Wu Q, Tang Y, Zhou Z, Feng M. The influence of esmolol on septic shock and sepsis: a meta-analysis of randomized controlled studies. Am J Emerg Med. 2018, 36:470-4. 10.1016\/j.ajem.2017.11.013","journal-title":"Am J Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100571","article-title":"Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: subanalysis of the J-Land 3S randomised controlled study","volume":"28","author":"Matsuda N","year":"2020","unstructured":"Matsuda N, Nishida O, Taniguchi T, et al.. Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: subanalysis of the J-Land 3S randomised controlled study. EClinicalMedicine. 2020, 28:10.1016\/j.eclinm.2020.100571","journal-title":"EClinicalMedicine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/cc13878","article-title":"Should \u03b2-blockers be used in septic shock?","volume":"18","author":"Lira A","year":"2014","unstructured":"Lira A, Pinsky MR. Should \u03b2-blockers be used in septic shock?. Crit Care. 2014, 18:304. 10.1186\/cc13878","journal-title":"Crit Care"},{"key":"ref17","article-title":"Selective beta-1 blockers","author":"Tucker WD","year":"2024","unstructured":"Tucker WD, Sankar P, Kariyanna PT. Selective beta-1 blockers. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref18","article-title":"Beta adrenergic blocking agents","year":"2012","unstructured":"Beta adrenergic blocking agents. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2012."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196901000-00007","article-title":"The treatment of endotoxin shock by beta adrenergic blockade","volume":"169","author":"Berk JL","year":"1969","unstructured":"Berk JL, Hagen JF, Beyer WH, Gerber MJ, Dochat GR. The treatment of endotoxin shock by beta adrenergic blockade. Ann Surg. 1969, 169:74-81. 10.1097\/00000658-196901000-00007","journal-title":"Ann Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli A","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, et al.. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013, 310:1683-91. 10.1001\/jama.2013.278477","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001078","article-title":"\u03b21-adrenergic inhibition improves cardiac and vascular function in experimental septic shock","volume":"43","author":"Kimmoun A","year":"2015","unstructured":"Kimmoun A, Louis H, Al Kattani N, et al.. \u03b21-adrenergic inhibition improves cardiac and vascular function in experimental septic shock. Crit Care Med. 2015, 43:332-40. 10.1097\/CCM.0000000000001078","journal-title":"Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278943-efficacy-of--blockers-in-decreasing-mortality-in-sepsis-and-septic-shock-patients-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T21:25:24Z","timestamp":1723670724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278943-efficacy-of--blockers-in-decreasing-mortality-in-sepsis-and-septic-shock-patients-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.66888","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}